Interrupting highly active antiretroviral therapy in patients with HIV.

about

Structured treatment interruptions (STI) in chronic unsuppressed HIV infection in adults Structured treatment interruptions (STI) in chronic suppressed HIV infection in adults Immune deficiency in HIV-1 infection: novel therapeutic approaches targeting innate and adaptive responses.

P2860

Q24245541-CEEDE840-2DE8-469A-8B86-3D5A8873F11C Q24245709-792EF168-DAA3-4FC0-947D-0609C701B062 Q40377124-535DBC6E-8239-4C7B-9987-E67EFFD4F7C1

P2860

Interrupting highly active antiretroviral therapy in patients with HIV.

Item

http://www.wikidata.org/entity/Q36066209

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Interrupting highly active antiretroviral therapy in patients with HIV.

@ast

Interrupting highly active antiretroviral therapy in patients with HIV.

@en

type

Item

label

Interrupting highly active antiretroviral therapy in patients with HIV.

@ast

Interrupting highly active antiretroviral therapy in patients with HIV.

@en

prefLabel

Interrupting highly active antiretroviral therapy in patients with HIV.

@ast

Interrupting highly active antiretroviral therapy in patients with HIV.

@en

P1476

Interrupting highly active antiretroviral therapy in patients with HIV.

@en

P2860

Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

Recurring thrombocytopenia associated with structured treatment interruption in patients with human immunodeficiency virus infection.

HIV-1-specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy.

Short-cycle structured intermittent treatment of chronic HIV infection with highly active antiretroviral therapy: effects on virologic, immunologic, and toxicity parameters.

Cellular immune response to human immunodeficiency virus.

Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy.

Human immunodeficiency virus-specific CD8(+) T-cell responses do not predict viral growth and clearance rates during structured intermittent antiretroviral therapy.

Viral evolution during structured treatment interruptions in chronically human immunodeficiency virus-infected individuals

Structured treatment interruptions for the management of HIV infection.

P304

51-60

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14787210.3.1.51

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Bernard Hirschel

Jintanat Ananworanich

P577

2005-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15757457

http://www.w3.org/2001/XMLSchema#string

Interrupting highly active antiretroviral therapy in patients with HIV.

about

P2860

P2860

Interrupting highly active antiretroviral therapy in patients with HIV.

description

name

type

label

prefLabel

P1433

P1476

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2860

P304

P31

P356

P433

P478

P50

P577

P698